glp 1 versus phentermine Christine Persaud MD MBA | Sports Medicine Physician | Weight Loss Medications - #weightlossmedication Phentermine vs GLP-1 Medications: Which

Talk with your healthcare provider about these risks

3.3 The mechanistic GLP-1/GIP/GCG receptors triple agonists in MASLD 3.3.1 Metabolic effects The development of triple receptor agonists targeting GLP-1, GIP, and GCG receptors represents a promising advancement in the treatment of MASLD

But the price point raises its own questions, particularly around who this serves and who it doesn't as coverage remains fragmented across the Canadian benefits landscape

Looking ahead, Novo Nordisk announced in February 2026 that the list price of Rybelsus will drop to $675 per month starting January 1, 2027a reduction of approximately 35%